These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19964269)

  • 1. Influence of channel blockers on cardiac alternans.
    Xia H; Zhao X; Bains J; Wortham DC
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():2823-6. PubMed ID: 19964269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis.
    Chay TR
    J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives.
    Pugsley MK; Yong SL; Goldin AL; Hayes ES; Walker MJA
    Eur J Pharmacol; 2019 Feb; 844():241-252. PubMed ID: 30571955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry.
    Comtois P; Kneller J; Nattel S
    Europace; 2005 Sep; 7 Suppl 2():10-20. PubMed ID: 16102499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium channel blockers in the treatment of ventricular arrhythmias: different effects in the normal, ischaemic or failing heart?
    Haverkamp W; Hindricks G; Fechtrup C; Borggrefe M; Breithardt G
    Eur Heart J; 1991 Dec; 12 Suppl F():10-7. PubMed ID: 1666550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death.
    Englert HC; Heitsch H; Gerlach U; Knieps S
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):253-71. PubMed ID: 15326916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Na+ channels as therapeutic targets for antiarrhythmic agents.
    Glaaser IW; Clancy CE
    Handb Exp Pharmacol; 2006; (171):99-121. PubMed ID: 16610342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms.
    Moreno JD; Zhu ZI; Yang PC; Bankston JR; Jeng MT; Kang C; Wang L; Bayer JD; Christini DJ; Trayanova NA; Ripplinger CM; Kass RS; Clancy CE
    Sci Transl Med; 2011 Aug; 3(98):98ra83. PubMed ID: 21885405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proarrhythmic and antiarrhythmic actions of ion channel blockers on arrhythmias in the heart: model study.
    Chay TR
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H329-56. PubMed ID: 8760192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonlinear nature of the antiarrhythmic effects of lidocain].
    Moskalenko AV
    Biofizika; 2009; 54(1):62-7. PubMed ID: 19334634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of antiarrhythmic drugs in elderly patients.
    Frishman WH; Aronow WS
    Clin Geriatr Med; 2012 Nov; 28(4):575-615. PubMed ID: 23101572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of antiarrhythmic drugs.
    Capucci A; Aschieri D; Villani GQ
    Drugs Aging; 1998 Jul; 13(1):51-70. PubMed ID: 9679209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels.
    Pless SA; Galpin JD; Frankel A; Ahern CA
    Nat Commun; 2011 Jun; 2():351. PubMed ID: 21673672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear dynamics in cardiology.
    Krogh-Madsen T; Christini DJ
    Annu Rev Biomed Eng; 2012; 14():179-203. PubMed ID: 22524390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates.
    Roden DM
    Am J Cardiol; 1996 Aug; 78(4A):12-6. PubMed ID: 8780324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
    Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
    Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.